Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 81 users online. 3 members and 78 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

5 results in 0.0084 seconds.
Keywords
Members
Tags
develop x
  •  

  • HHS Provides 25 Million Dollars to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests

    U.S. Department of Health and Human Services Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests | site |


    Dual Contracts Will Yield Two New Antigen Tests and Update Massachusetts Facility to Produce up to 50 Million Tests Per Month


    (Information contained in U.S. Department of Health and Human Services press release: November 19, 2020) Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DoD) awarded Siemens Healthineers a $12 million contract to support domestic production of two diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The funding is in addition to a $13 million HHS contract awarded Nov. 2 to enable the company to develop the tests. Combined, the two contracts represent another $25 million investment by the federal government to expand the types of tests for COVID-19 and to ensure that sufficient numbers of tests are available ...
    See more | Go to post

  • U.S. Department of Energy to Provide 32 Million Dollars to Develop Advanced Chemical Sciences Software

    U.S. Department of Energy to Provide $32 Million to Develop Advanced Chemical Sciences Software| site |


    (November 2, 2020) - - On November 2, 2020 the U.S. Department of Energy published the following information: WASHINGTON, D.C. – Today, the U.S. Department of Energy (DOE) announced plans to provide up to $32 million for research to advance the development of sophisticated software for the chemical sciences. The effort aims to take advantage of the DOE national laboratories’ rapidly advancing supercomputing capabilities, including emerging exascale systems capable of a billion-billion operations per second, to accelerate the discovery and development of chemical mechanisms for a wide variety of potential applications. “The DOE national laboratories host some of the most powerful supercomputers in the world,” said Dr. Chris Fall, Director of DOE’s Office of Science. “This research will harness these extraordinary capabilities to advance our underst...
    See more | Go to post

  • HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections

    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections| site |



    (March 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: In response to the now global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), continues to work with its public-private partners to find solutions to mitigate the public health impact of the coronavirus disease 2019 (COVID-19). Part of this landscape is the immediate need for diagnostics tests that can quickly and accurately diagnose COVID-19 infections in order to identify the virus and mitigate the spread of the disease. BARDA will provide Mesa Biotech, Inc. of San Diego, California, with technical expertise and $561,330 in immediate funding to pursue eventual Food and Drug Administration (FDA) approval or clearance of its dia...
    See more | Go to post

  • U.S. Department of Health and Human Services and Janssen Collaborate To Develop Coronavirus Therapeutics

    U.S. Department of Health and Human Services and Janssen Collaborate To Develop Coronavirus Therapeutics| site |





    (February 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: As part of the rapid global response to the 2019 novel coronavirus (SARS-CoV-2), the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) will use an existing partnership with Janssen Research & Development, part of Johnson & Johnson, to help develop treatments for coronavirus infections. The Biomedical Advanced Research and Development Authority (BARDA), part of ASPR, will collaborate with Janssen to identify medicines that might be used safely and effectively to reduce the severity of illness and treat coronavirus infections. The company also will identify compounds that have antiviral activity against SARS-CoV-2 as an initial step in developing new
    ...
    See more | Go to post

  • U.S. Department of Health and Human Services Partners to Develop New Treatment for Seizures Caused by Nerve Agents

    U.S. Department of Health and Human Services Partners to Develop New Treatment for Seizures Caused by Nerve Agents




    (April 27, 2018) - - Today, the U.S. Department of Health and Human Services published the following information:

    A new treatment for seizures that cannot be stopped with current medicines will be developed under an agreement between the U.S. Department of Health and Human Services (HHS)’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Proniras Corporation of Seattle, Washington. Uncontrollable seizures are a devastating result of exposure to nerve agents and can be deadly or lead to permanent brain damage.

    “Nerve agents are the most toxic and rapidly acting of the known chemical warfare agents,” explained Rick Bright, Ph.D., director of the Biomedical Advanced Research and Development Authority (BARDA), a component of
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    HHS Provides 25 Million Dollars to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
    by Staff Reporter 1
    U.S. Department of Health and Human Services Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests | site |


    Dual Contracts Will Yield Two New Antigen Tests and Update Massachusetts Facility to Produce up to 50 Million Tests Per Month


    (Information contained in U.S. Department of Health and Human Services press release: November 19, 2020) Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DoD) awarded Siemens Healthineers a $12 million contract to support domestic production of two diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The funding is in addition to a $13 million HHS contract awarded Nov. 2 to enable the company to develop the tests. Combined, the two contracts represent another $25 million investment by the federal government to expand the types of tests for COVID-19 and to ensure that sufficient numbers of tests are available ...
    11-21-2020, 09:09 AM
  • Staff Reporter 1
    U.S. Department of Energy to Provide 32 Million Dollars to Develop Advanced Chemical Sciences Software
    by Staff Reporter 1
    U.S. Department of Energy to Provide $32 Million to Develop Advanced Chemical Sciences Software| site |


    (November 2, 2020) - - On November 2, 2020 the U.S. Department of Energy published the following information: WASHINGTON, D.C. – Today, the U.S. Department of Energy (DOE) announced plans to provide up to $32 million for research to advance the development of sophisticated software for the chemical sciences. The effort aims to take advantage of the DOE national laboratories’ rapidly advancing supercomputing capabilities, including emerging exascale systems capable of a billion-billion operations per second, to accelerate the discovery and development of chemical mechanisms for a wide variety of potential applications. “The DOE national laboratories host some of the most powerful supercomputers in the world,” said Dr. Chris Fall, Director of DOE’s Office of Science. “This research will harness these extraordinary capabilities to advance our underst...
    11-10-2020, 03:35 PM
  • Staff Reporter 1
    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections
    by Staff Reporter 1
    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections| site |



    (March 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: In response to the now global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), continues to work with its public-private partners to find solutions to mitigate the public health impact of the coronavirus disease 2019 (COVID-19). Part of this landscape is the immediate need for diagnostics tests that can quickly and accurately diagnose COVID-19 infections in order to identify the virus and mitigate the spread of the disease. BARDA will provide Mesa Biotech, Inc. of San Diego, California, with technical expertise and $561,330 in immediate funding to pursue eventual Food and Drug Administration (FDA) approval or clearance of its dia...
    03-18-2020, 08:47 PM
  • Staff Reporter 1
    U.S. Department of Health and Human Services and Janssen Collaborate To Develop Coronavirus Therapeutics
    by Staff Reporter 1
    U.S. Department of Health and Human Services and Janssen Collaborate To Develop Coronavirus Therapeutics| site |





    (February 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: As part of the rapid global response to the 2019 novel coronavirus (SARS-CoV-2), the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) will use an existing partnership with Janssen Research & Development, part of Johnson & Johnson, to help develop treatments for coronavirus infections. The Biomedical Advanced Research and Development Authority (BARDA), part of ASPR, will collaborate with Janssen to identify medicines that might be used safely and effectively to reduce the severity of illness and treat coronavirus infections. The company also will identify compounds that have antiviral activity against SARS-CoV-2 as an initial step in developing new
    ...
    02-19-2020, 02:24 AM
  • Staff Reporter 1
    U.S. Department of Health and Human Services Partners to Develop New Treatment for Seizures Caused by Nerve Agents
    by Staff Reporter 1
    U.S. Department of Health and Human Services Partners to Develop New Treatment for Seizures Caused by Nerve Agents




    (April 27, 2018) - - Today, the U.S. Department of Health and Human Services published the following information:

    A new treatment for seizures that cannot be stopped with current medicines will be developed under an agreement between the U.S. Department of Health and Human Services (HHS)’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Proniras Corporation of Seattle, Washington. Uncontrollable seizures are a devastating result of exposure to nerve agents and can be deadly or lead to permanent brain damage.

    “Nerve agents are the most toxic and rapidly acting of the known chemical warfare agents,” explained Rick Bright, Ph.D., director of the Biomedical Advanced Research and Development Authority (BARDA), a component of
    ...
    05-04-2018, 02:04 PM

Menu

Collapse

Menu

Collapse

Working...
X